Brookfield Asset Management is reportedly seeking 9.5 billion euros ($10.6 billion) in debt financing for a potential take-private deal for Grifols SA (NASDAQ:GRFS), a Spanish pharmaceutical company. In a July regulatory filing, Grifols said that Brookfield Capital has confirmed that it has engaged in preliminary discussions with Grifols’s key shareholders regarding a potential joint offer to delist the company’s shares from the Spanish stock exchanges and NASDAQ. The investment firm has approached banks to secure funding to refinance Grifols’ existing debt, which includes loans and high-yield…
